An observational study in Abdominal Aortic Aneurysm and Image, sponsored by RenJi Hospital. Recruiting at 1 site in China. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-06-26.
Sponsored by RenJi Hospital · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 17 studies in Aortic Aneurysm, Abdominal with a site in China — 7 open to participants now, 9 under way, none of them phase 3. Aortic Aneurysm, Abdominal · China.
Among the 17 studies in Aortic Aneurysm, Abdominal with a site in China, this one is the only one that started in 2020, is one of 9 observational ones, and was the 14th registered.
467 studies on the registry are indexed under Aortic Aneurysm, Abdominal; 99 are open to participants now.
Browse Aortic Aneurysm, Abdominal studies →7 of the 17 studies in Aortic Aneurysm, Abdominal with a site in China are open now. Recruiting first, the newest first:
Medtronic Cardiovascular · Sites in China
Ages 18+
Shanghai MicroPort Endovascular MedTech(Group)Co., Ltd · Sites in China, Germany, Greece and 3 more countries
Ages 18+
First Affiliated Hospital of Kunming Medical University · Sites in China
Ages 20–90
RenJi Hospital · Sites in China
Ages 50+
RenJi Hospital · Sites in China
Ages 18+
A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →
Of the 66 Aortic Aneurysm, Abdominal studies recruiting now, 52 (79%) set no upper age limit and 3 (5%) stop at 75 or younger; 2 take children under 18; 8 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
17 studies; the count open now beside each. This study's row is marked.
First in 2008; this study’s year is marked. 1 started in 2020.
This study's planned enrollment of 1,000 is above the median of 165 across 217 observational studies indexed under Aortic Aneurysm, Abdominal.
Median enrollment 113 across the 8 interventional studies, 200 across the 9 observational. Of the 4 that completed or were terminated, 1 (25%) have results posted.
This tab as a report to print or save as PDF → With an account.
9 of 17 have an industry lead sponsor. The 10 most frequent:
RenJi Hospital is the lead sponsor of 551 studies on the registry; 248 are open to participants now.
RenJi Hospital has 4 studies filed under Aortic Aneurysm, Abdominal — fewer than ten, so there is no comparison to draw.
2 of the studies in Aortic Aneurysm, Abdominal with a site in China that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05133492Nectero Medical, Inc.First In Human Study for Small to Medium-sized Abdominal Aortic Aneurysm (AAA) | 2026-12-31 |
| NCT07039825RenJi HospitalAAA-CTA Cohort Registry | 2027-05-01 |
Add all 2 to your calendar (.ics) → With an account.
Among the 17 studies in Aortic Aneurysm, Abdominal with a site in China, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The aim of this study is to investigate the measurement of abdominal aortic aneurysm by computed tomography angiography. The research will collected the results of computed tomography angiography from inpatient, emergency, and outpatient populations with abdominal aortic aneurysm.
Abdominal aortic aneurysm (AAA) is a life-threatening vascular disorder characterized by irreversible dilation of the abdominal aorta, posing a significant risk of rupture and catastrophic hemorrhage, with mortality rates reaching 65-85% upon rupture. Given the often asymptomatic nature of AAA until rupture, early detection and precise monitoring are critical to prevent fatal outcomes, underscoring the urgent need for reliable diagnostic tools.
Computed tomography angiography (CTA) has emerged as a gold-standard non-invasive imaging technique, offering high-resolution visualization of AAA morphology, including aneurysm diameter, wall thickness, thrombus formation, and spatial relationship to adjacent structures, which are essential for accurate diagnosis, rupture risk stratification, and surgical planning.
This study aims to investigate the precision and clinical utility of CTA in AAA measurement, with the potential to optimize screening protocols, improve intervention timing, and ultimately reduce AAA-related mortality.
By establishing standardized CTA-based assessment criteria, this research may contribute to enhanced diagnostic workflows, better patient risk stratification, and more personalized treatment strategies, thereby addressing a critical gap in vascular disease management.
Patients with abdominal aortic aneurysm undergoing computed tomography angiography
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
1. Patients who declined participation, cases with incomplete or missing clinical data.
The results of computed tomography angiography on abdominal aortic aneurysm are collected.
Maximal abdominal aortic diameter
The images of computed tomography angiography on abdominal aortic aneurysm are collected and the maximal diameter of abdominal artery is measured by medical specialists.
Time frame: 1 month
Rupture
The images of computed tomography angiography on abdominal aortic aneurysm are collected and the rupture of AAA is judged by medical specialists.
Time frame: 1 month
Mortality
The death of AAA patients is recorded and mortality is calculated.
Time frame: 1 month
Other characteristics of AAA morphology
Through CTA images, the existence of ulcer, mural thrombus is judged, and the length of AAA is measured by medical specialists.
Time frame: 1 month
Plan to share: Undecided
No publications or documents are linked to this record.
Started Jan 2020 (actual). Primary completion is estimated for May 2027, 88 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.